These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 38325076)
61. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680 [TBL] [Abstract][Full Text] [Related]
62. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122 [TBL] [Abstract][Full Text] [Related]
63. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
64. Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid Carriers. Gupta B; Poudel BK; Tran TH; Pradhan R; Cho HJ; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO Pharm Res; 2015 Sep; 32(9):2912-27. PubMed ID: 25939551 [TBL] [Abstract][Full Text] [Related]
65. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related]
66. Development of a long-acting tablet with ticagrelor high-loaded nanostructured lipid carriers. Jung M; Jin M; Jeon WJ; Lee H; Kim H; Won JH; Yoo H; Bai HW; Han SC; Suh H; Kang KU; Lee HK; Cho CW Drug Deliv Transl Res; 2023 May; 13(5):1212-1227. PubMed ID: 35794353 [TBL] [Abstract][Full Text] [Related]
67. Nanostructured lipid carriers as a delivery system of biochanin A. Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887 [TBL] [Abstract][Full Text] [Related]
68. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Baek JS; Pham CV; Myung CS; Cho CW Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175 [TBL] [Abstract][Full Text] [Related]
69. Nanostructured-lipid carriers-Chitosan hydrogel beads carrier system for loading of resveratrol: A new method of topical application. Wu B; Li Y; Li YY; Shi ZH; Bian XH; Xia Q J Biomater Appl; 2022 Mar; 36(8):1444-1457. PubMed ID: 34995470 [TBL] [Abstract][Full Text] [Related]
70. Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of Polymyxin B. Pattani AS; Mandawgade SD; Patravale VB J Nanosci Nanotechnol; 2006; 6(9-10):2986-90. PubMed ID: 17048508 [TBL] [Abstract][Full Text] [Related]
71. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability. Teeranachaideekul V; Müller RH; Junyaprasert VB Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778 [TBL] [Abstract][Full Text] [Related]
72. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery. Shrivastava N; Khan S; Baboota S; Ali J Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155 [TBL] [Abstract][Full Text] [Related]
73. Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. Li B; Ge ZQ AAPS PharmSciTech; 2012 Mar; 13(1):276-83. PubMed ID: 22234598 [TBL] [Abstract][Full Text] [Related]
74. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
75. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers]. Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576 [TBL] [Abstract][Full Text] [Related]
76. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
77. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study. Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230 [TBL] [Abstract][Full Text] [Related]
79. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. Cunha S; Swedrowska M; Bellahnid Y; Xu Z; Sousa Lobo JM; Forbes B; Silva AC Int J Pharm; 2022 May; 620():121720. PubMed ID: 35413397 [TBL] [Abstract][Full Text] [Related]
80. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design. Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]